| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/25/2013 | CN102836148B Medicine compound for curing cervical diseases |
| 12/25/2013 | CN102824417B New method for treating helicobacter pylori related diseases |
| 12/25/2013 | CN102784316B Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method |
| 12/25/2013 | CN102746226B Acridine derivative and preparation method and application thereof |
| 12/25/2013 | CN102731376B Gimeracil crystal form and preparation method thereof |
| 12/25/2013 | CN102697731B 5-aminolevulinic acid nano particle as well as preparation method and device thereof |
| 12/25/2013 | CN102688246B Phlomis umbrosa root total-drop triterpene composition and extraction method and application thereof |
| 12/25/2013 | CN102614110B Stable polyethylene glycol medicinal micelle composition and preparation method thereof |
| 12/25/2013 | CN102603761B Etoposide compound with hydroxamic acid structure and preparation method and usage thereof |
| 12/25/2013 | CN102526714B Medicine composition for curing tumour and preparation method thereof |
| 12/25/2013 | CN102504006B Steroid saponin compound in siberian fritillary bulb |
| 12/25/2013 | CN102492006B Canthaxanthin compound and application of compound to preparation of antitumor drugs |
| 12/25/2013 | CN102470136B PLK inhibitor salts |
| 12/25/2013 | CN102462730B Traditional Chinese medicine composition for treating tumors |
| 12/25/2013 | CN102344351B Aryl-substituted chalcones compound, its preparation method and its application |
| 12/25/2013 | CN102311502B Fusion protein used for inhibiting regeneration or growth of blood vessel and medical treatment application thereof |
| 12/25/2013 | CN102285993B Tetrahydropyridine oxapicene derivative as well as preparation method and application thereof |
| 12/25/2013 | CN102174046B Tetomilast polymorphs |
| 12/25/2013 | CN102164920B Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 12/25/2013 | CN102146076B Anilinoquinazoline derivatives and preparation method thereof |
| 12/25/2013 | CN102143953B Pyrimidines, triazines and their use as pharmaceutical agents |
| 12/25/2013 | CN101935306B Diketone piperazidine-like derivative and application thereof |
| 12/25/2013 | CN101868465B Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
| 12/25/2013 | CN101747170B Conjugated type coenzyme Q analogue, preparation method and application thereof |
| 12/25/2013 | CN101732258B Nano microsphere preparation used for chemotherapy of tumors and preparation method thereof |
| 12/25/2013 | CN101653561B Ceramide production accelerant |
| 12/25/2013 | CN101652388B Monoclonal human tumor-specific antibody |
| 12/25/2013 | CN101501070B Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 12/25/2013 | CN101100466B Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application |
| 12/24/2013 | US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase |
| 12/24/2013 | US8614223 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 12/24/2013 | US8614208 Fused heterocyclic ring derivative and use thereof |
| 12/24/2013 | US8614177 Peptides |
| 12/24/2013 | US8614176 Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
| 12/24/2013 | CA2783175C Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 12/24/2013 | CA2759060C A drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic |
| 12/24/2013 | CA2714181C Ampk modulators |
| 12/24/2013 | CA2620472C Substituted benzimidazoles as kinase inhibitors |
| 12/24/2013 | CA2613059C Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 12/24/2013 | CA2611450C Method for producing polymerized coordination compounds of platinum complex |
| 12/24/2013 | CA2600606C Indanes |
| 12/24/2013 | CA2575787C Dihydropteridinones for the treatment of cancer diseases |
| 12/24/2013 | CA2553248C Treatment of cancer using benzoic acid derivatives |
| 12/24/2013 | CA2520372C Stq-peptides |
| 12/24/2013 | CA2517136C Composition for treating hepatitis c |
| 12/24/2013 | CA2395945C Novel chimeric proteins and methods for using the same |
| 12/24/2013 | CA2393816C Process for obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ros scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 12/24/2013 | CA2375104C Prevention and treatment of amyloidogenic disease |
| 12/24/2013 | CA2349762C Human tslp dna and polypeptides |
| 12/19/2013 | WO2013188874A1 Methods of mitigating side effects of radiation exposure and chemotherapy |
| 12/19/2013 | WO2013188856A1 Imidazopyrazine syk inhibitors |
| 12/19/2013 | WO2013188813A2 Novel therapeutics for brain cancer |
| 12/19/2013 | WO2013188783A1 Deuterated derivatives of ruxolitinib |
| 12/19/2013 | WO2013188763A1 Compositions for treating cancer and methods for making the same |
| 12/19/2013 | WO2013188750A2 Substituted macrocyclic compounds having proteasome inhibitory activity |
| 12/19/2013 | WO2013188586A1 Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
| 12/19/2013 | WO2013188452A1 Compounds and methods of treating cancer |
| 12/19/2013 | WO2013188355A1 Cdk inhibitor for treating refractory chronic lymphocytic leukemia |
| 12/19/2013 | WO2013188184A1 Inhibitor of jak1 and jak2 |
| 12/19/2013 | WO2013188138A1 Inhibitors of hippo-yap signaling pathway |
| 12/19/2013 | WO2013187965A1 Pyrazole derivatives as inhibitors of stat3 |
| 12/19/2013 | WO2013187724A1 Novel antibody specific for clec14a and uses thereof |
| 12/19/2013 | WO2013187556A1 Novel antibody specific for clec14a and uses thereof |
| 12/19/2013 | WO2013187391A1 COMPOSITION COMPRISING SESAMIN COMPOUND, γ-ORIZANOL AND RICE GERM OIL |
| 12/19/2013 | WO2013187069A1 Pdt effect enhancing agent |
| 12/19/2013 | WO2013187052A1 Anti-colon cancer agent |
| 12/19/2013 | WO2013186857A1 Aptamer to fgf2 and use thereof |
| 12/19/2013 | WO2013186793A1 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells |
| 12/19/2013 | WO2013186734A1 Chemoprevention of colorectal cancer |
| 12/19/2013 | WO2013186612A1 The use of substituted 2-phenyl-3h-quinazolin-4-ones and analogs for inhibiting bet (bromodomain and extra terminal domain) proteins |
| 12/19/2013 | WO2013186355A1 A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota |
| 12/19/2013 | WO2013186236A1 Antagonists of il-17 isoforms and their uses |
| 12/19/2013 | WO2013186159A1 New diazaspirocycloalkane and azaspirocycloalkane |
| 12/19/2013 | WO2013185635A1 Polyoxopregnane compounds and use thereof |
| 12/19/2013 | WO2013185613A1 Acylation derivatives of paridis saponins i, preparation method therefor and application thereof |
| 12/19/2013 | WO2013185552A1 Dual-signal independent chimeric antigen receptor and use thereof |
| 12/19/2013 | WO2013185353A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 12/19/2013 | WO2013185298A1 Chinese medicine for treating breast cancer |
| 12/19/2013 | WO2013185284A1 Pyridinone and pyridazinone derivatives |
| 12/19/2013 | WO2013185241A1 Aptamers specific to cea and tnf-alpha and their therapeutic uses |
| 12/19/2013 | WO2013185215A1 Antibodies and conjugates that target misfolded prion protein |
| 12/19/2013 | WO2013185202A1 Apoptosis inducers |
| 12/19/2013 | WO2013142255A3 Bi-specific binding agents |
| 12/19/2013 | US20130338188 Pharmaceutical compositions and administrations thereof |
| 12/19/2013 | US20130338151 Fused ring analogues of anti-fibrotic agents |
| 12/19/2013 | US20130338148 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 12/19/2013 | US20130337039 Internalizing ErBB2 Antibodies |
| 12/19/2013 | US20130336889 Nanoparticle and method for detecting or treating a tumor using the same |
| 12/19/2013 | DE102010023850B4 Funktionalisierte Nanopartikel mit verbesserter Bioverfügbarkeit Functionalized nanoparticles with improved bioavailability |
| 12/19/2013 | CA2877505A1 Antibodies and conjugates that target misfolded prion protein |
| 12/19/2013 | CA2876796A1 Humanized antibodies to ca215 |
| 12/19/2013 | CA2876539A1 Multicomponent crystals comprising dasatinib and selected co-crystal formers |
| 12/19/2013 | CA2876306A1 Deuterated derivatives of ruxolitinib |
| 12/19/2013 | CA2876299A1 Chemoprevention of colorectal cancer |
| 12/19/2013 | CA2875824A1 Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
| 12/19/2013 | CA2875372A1 Compound as wnt signaling inhibitor, composition, and use thereof |
| 12/19/2013 | CA2874953A1 Pyridinone and pyridazinone derivatives |
| 12/18/2013 | EP2674433A1 LIMK2 inhibitors, compositions comprising them and methods of their use |
| 12/18/2013 | EP2674415A1 Homo- and hetero-polyamino-acid derivatives of fullerene c60, method for producing same, and pharmaceutical compositions based on said derivatives |
| 12/18/2013 | EP2674170A1 Novel compositions of TLR7 and/or TLR8 agonists conjugated to lipids |